Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01350544 · ClinicalTrials.gov registry record · NA
Treatment Advocacy Intervention for HIV-Positive African Americans
A NA study of HIV, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 216
- Enrollment target
- 1
- Study location
NCT01350544: Completed NA study of HIV, sponsored by Boston Children's Hospital.
NCT01350544 is a NA study of HIV that has completed, run by Boston Children's Hospital. The registered enrollment target is 216 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01350544, a NA study of HIV, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 216 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hypothesize that participants in the treatment advocacy intervention will show significantly better HIV treatment adherence than will participants in the no-treatment (wait-list) control group.
Primary Outcome
We used a repeated measures linear regression modeling continuous adherence with intervention, linear time, and their interaction, and demographic covariates. Continuous adherence is measured as average percentages of doses taken.
Conditions Studied
Interventions
- BEHAVIORAL Treatment Advocacy
Study Locations (1)
California
- AIDS Project Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2013-04 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT01350544 record still lists
NCT01350544 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (51% lower).
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Treatment Advocacy is the first listed.
NCT01350544 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01350544 about?
NCT01350544 is a clinical study titled "Treatment Advocacy Intervention for HIV-Positive African Americans". The investigators hypothesize that participants in the treatment advocacy intervention will show significantly better HIV treatment adherence than will participants in the no-treatment (wait-list) control group.
What is the current status of trial NCT01350544?
This trial is currently completed. It is a NA study. The enrollment target is 216 participants. The study started on 2013-04. Estimated completion is 2015-12.
What conditions does trial NCT01350544 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT01350544?
The interventions under investigation include: Treatment Advocacy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01350544?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01350544 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01350544's enrollment target sits among peer trials
216 98th of 303 higher than 206 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02609685 · 216 participants · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia